52 related articles for article (PubMed ID: 26826415)
1. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
4. An integrative approach for exploring the nature of fibroepithelial neoplasms.
Yun J; Heo W; Lee ES; Na D; Kang W; Kang J; Chae J; Lee D; Lee W; Hwang J; Yoo TK; Hong BS; Son HY; Noh DY; Lee C; Moon HG; Kim JI
Br J Cancer; 2023 Feb; 128(4):626-637. PubMed ID: 36522480
[TBL] [Abstract][Full Text] [Related]
5. Can Mitotic Figures in Hyperchromatic Crowded Groups be Cytodiagnostic Criteria for High-Grade Squamous Intra-epithelial Lesions?
Suzuki H; Kondo Y; Oda C; Nishikawa T; Takeuchi M; Tatsumi S; Hosokawa S; Irino S; Uchiyama T; Fujii T; Norimatsu Y
J Cytol; 2024; 41(2):116-122. PubMed ID: 38779606
[TBL] [Abstract][Full Text] [Related]
6. Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.
Olar A
Neuro Oncol; 2015 May; 17(5):631-3. PubMed ID: 25813470
[No Abstract] [Full Text] [Related]
7. Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks.
Tellez D; Balkenhol M; Otte-Holler I; van de Loo R; Vogels R; Bult P; Wauters C; Vreuls W; Mol S; Karssemeijer N; Litjens G; van der Laak J; Ciompi F
IEEE Trans Med Imaging; 2018 Sep; 37(9):2126-2136. PubMed ID: 29994086
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of paralogous 13 HOX genes in phyllodes tumor of the breast as a useful diagnostic tool.
Sarno S; Cerrone M; Gigantino V; Scognamiglio G; Cantile M; Botti G; Di Bonito M
Int J Clin Exp Pathol; 2020; 13(9):2348-2351. PubMed ID: 33042341
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application.
Ibrahim A; Jahanifar M; Wahab N; Toss MS; Makhlouf S; Atallah N; Lashen AG; Katayama A; Graham S; Bilal M; Bhalerao A; Ahmed Raza SE; Snead D; Minhas F; Rajpoot N; Rakha E
Mod Pathol; 2024 Mar; 37(3):100416. PubMed ID: 38154653
[TBL] [Abstract][Full Text] [Related]
10. "Errata" does anyone read them? Revisiting mitotic counts in mast cell tumors.
Meuten DJ; Moore FM; Kass PH; London CA; Reilly CM; Romansik EM; R Sueiro FA
Vet Pathol; 2024 May; ():3009858241246987. PubMed ID: 38742653
[No Abstract] [Full Text] [Related]
11. Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Schmidt H; Steiniche T
Diagn Pathol; 2016 Apr; 11():35. PubMed ID: 27062658
[TBL] [Abstract][Full Text] [Related]
12. The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study.
Chow KL; Tse KY; Cheung CL; Wong KW; Cheung AN; Wong RW; Chan AN; Yuen NW; Ngan HY; Ip PP
Histopathology; 2017 Apr; 70(5):746-755. PubMed ID: 27864989
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
[TBL] [Abstract][Full Text] [Related]
14. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
Markouli M; Strepkos D; Piperi C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
[TBL] [Abstract][Full Text] [Related]
15. Histone Modifications and Their Targeting in Lymphoid Malignancies.
Fernández-Serrano M; Winkler R; Santos JC; Le Pannérer MM; Buschbeck M; Roué G
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008680
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic culture enhances the expansion of rat bone marrow-derived mesenchymal stem cells via the regulatory pathways of cell division and apoptosis.
Zhang J; Xiong L; Tang W; Tang L; Wang B
In Vitro Cell Dev Biol Anim; 2018 Oct; 54(9):666-676. PubMed ID: 30136033
[TBL] [Abstract][Full Text] [Related]
17. The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.
Kim JY; Jeong HS; Chung T; Kim M; Lee JH; Jung WH; Koo JS
Oncotarget; 2017 Sep; 8(39):65064-65076. PubMed ID: 29029412
[TBL] [Abstract][Full Text] [Related]
18. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.
Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM
Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415
[TBL] [Abstract][Full Text] [Related]
19. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
